Educational information, not medical advice.See how evidence is graded

Agaricus subrufescens

Traditionally used for: General immune support; Supportive care during cancer treatment; Blood sugar in type 2 diabetes; Inflammatory bowel symptoms.

Home

What is Agaricus subrufescens? Agaricus subrufescens is an edible mushroom sold as a supplement for "immune support". You will also see it called Agaricus blazei, almond mushroom or himematsutake. It is grown on farms in Brazil, Japan, China and parts of Europe. The dried mushroom is sold as powder, capsules, tea and liquid extracts. Most products are marketed for immunity, cancer support or blood sugar. Here is the honest verdict on the evidence. Human testing is limited to a handful of small trials, and the results are mixed. The mushroom has been eaten as food for decades, but food use is not proof that it treats anything, and it is not proof that concentrated extracts are safe. This page does not claim any cure. If you are weighing it up, the main things to know are the thin evidence and the reports of liver trouble in a few users. How does Agaricus subrufescens work? No one has shown how this mushroom works in the human body. The usual explanation rests on lab work, not on people. The mushroom is rich in beta-glucans. These are long sugar chains found in fungal cell walls. In test tubes and in mice, beta-glucans appear to switch on parts of the immune system. They seem to bind to receptors on white blood cells. Whether the same thing happens when you swallow a capsule is not established. Lab studies also report that extracts slow the growth of some tumour cell lines. Animal work has shown effects on blood sugar and on gut inflammation. These are early findings in cells and rodents. They do not show that the mushroom treats cancer, diabetes or bowel disease in people. Treat any marketing that skips this gap with suspicion. What forms does Agaricus subrufescens come in? You will find it in several forms: - Dried mushroom pieces, used as food or simmered into a broth. - Powder, loose or in capsules. - Hot-water extracts, sold as liquid drinks or concentrated powders. - Teas and instant granules. - Blended "mushroom complex" products mixed with reishi, maitake or shiitake. Naming is a real problem here. The same mushroom is sold as Agaricus blazei, which is in fact a different species. Mislabelling and mixed batches have been reported, so brand quality matters. Where it comes from: The mushroom was noted near Piedade, in south-east Brazil, in the mid-1900s. Local farming families ate it and brewed it as a drink. Samples went to Japan in the 1960s and 1970s. There it was named himematsutake and became a popular health product. Interest spread to Korea, China and then Europe. Past users took it for general strength, for long illness and alongside cancer care. Those were folk reports, not trials. The tradition is also recent by herbal standards, under a century old.

Helps

What does Agaricus subrufescens help with? General immune support: This is the most common marketing claim. It rests mainly on cell and animal studies of beta-glucans. Some small human studies report changes in immune markers in the blood. Changes in markers are not the same as getting ill less often. No good trial has shown fewer colds or fewer infections in people who take it. Supportive care during cancer treatment: Past users in Japan and Brazil took it alongside cancer care. Lab work shows extracts slowing some tumour cells in a dish. Human evidence is weak. Small studies have looked at quality of life and side effects during chemotherapy, with mixed and unclear results. It is not a cancer treatment and must never replace one. Liver injury has been reported in cancer patients using these extracts, so your oncologist needs to know. Blood sugar in type 2 diabetes: This is the one use with a published randomised trial. The trial added the extract to standard diabetes medicine for 12 weeks . It reported better insulin sensitivity than placebo. The study was small and has not been repeated at a larger size. That is promising but not proof. It is also the reason for care if you already take diabetes medicine. Inflammatory bowel symptoms: A mushroom-based drink built around this species has been tested in Crohn's disease and ulcerative colitis in Norway. The studies were small and single-blinded. Some markers of inflammation shifted. Symptom benefit was not clearly shown. This use should be seen as unproven. Tiredness and general wellbeing: Folk use included it as a tonic for people worn down by illness. There is no solid trial evidence for energy or wellbeing. If you feel very tired, the cause is worth finding. See a doctor rather than self-treating with a supplement.

Agaricus subrufescens

Quick Facts

  • What it is: An edible Brazilian mushroom, also sold as Agaricus blazei, taken as a supplement for immune support.
  • Main uses: General immune support, Supportive care during cancer treatment, Blood sugar in type 2 diabetes, Inflammatory bowel symptoms
  • Active ingredients: Beta-glucans, Proteoglycans, Ergosterol, Agaritine
  • Forms: Dried mushroom, Powder, Capsules, Hot-water extract, Liquid drink, Tea
  • Time to effect: No reliable timeframe; trials ran 6 to 12 weeks, and it may do nothing.
  • Side effects: Usually mild stomach upset; rare but real reports of liver injury.
  • Pregnancy & breastfeeding: Avoid in pregnancy and while breastfeeding.

Educational information, not medical advice — ask your doctor or midwife.

What is Agaricus subrufescens?

Agaricus subrufescens is an edible mushroom sold as a supplement for "immune support". You will also see it called Agaricus blazei, almond mushroom or himematsutake.

It is grown on farms in Brazil, Japan, China and parts of Europe. The dried mushroom is sold as powder, capsules, tea and liquid extracts. Most products are marketed for immunity, cancer support or blood sugar.

Here is the honest verdict on the evidence. Human testing is limited to a handful of small trials, and the results are mixed. The mushroom has been eaten as food for decades, but food use is not proof that it treats anything, and it is not proof that concentrated extracts are safe.

This page does not claim any cure. If you are weighing it up, the main things to know are the thin evidence and the reports of liver trouble in a few users.

How does Agaricus subrufescens work?

No one has shown how this mushroom works in the human body. The usual explanation rests on lab work, not on people.

The mushroom is rich in beta-glucans. These are long sugar chains found in fungal cell walls.

In test tubes and in mice, beta-glucans appear to switch on parts of the immune system. They seem to bind to receptors on white blood cells. Whether the same thing happens when you swallow a capsule is not established.

Lab studies also report that extracts slow the growth of some tumour cell lines. Animal work has shown effects on blood sugar and on gut inflammation. These are early findings in cells and rodents.

They do not show that the mushroom treats cancer, diabetes or bowel disease in people. Treat any marketing that skips this gap with suspicion.

What forms does Agaricus subrufescens come in?

You will find it in several forms:

- Dried mushroom pieces, used as food or simmered into a broth.

- Powder, loose or in capsules.

- Hot-water extracts, sold as liquid drinks or concentrated powders.

- Teas and instant granules.

- Blended "mushroom complex" products mixed with reishi, maitake or shiitake.

Naming is a real problem here. The same mushroom is sold as Agaricus blazei, which is in fact a different species. Mislabelling and mixed batches have been reported, so brand quality matters.

Where it comes from:

The mushroom was noted near Piedade, in south-east Brazil, in the mid-1900s. Local farming families ate it and brewed it as a drink.

Samples went to Japan in the 1960s and 1970s. There it was named himematsutake and became a popular health product. Interest spread to Korea, China and then Europe.

Past users took it for general strength, for long illness and alongside cancer care. Those were folk reports, not trials. The tradition is also recent by herbal standards, under a century old.

Who should avoid Agaricus subrufescens?

  • Do not use it as a replacement for cancer treatment, and tell your oncologist before you start.
  • Do not use if you have liver disease, hepatitis, or liver enzymes that are already raised.
  • Do not use if you take medicines that lower the immune system (immunosuppressive drugs) after a transplant, such as ciclosporin or tacrolimus.
  • Do not use if you are pregnant or breastfeeding, because safety data are missing.
  • Do not give it to children.
  • Avoid it if you are allergic to mushrooms or react badly to moulds.
  • Do not start it alongside insulin or other diabetes medicine without your diabetes team's agreement.
  • Avoid it if you have kidney disease, unless your kidney doctor agrees.
  • Do not take it in the two weeks before planned surgery without telling your surgeon.

When should you see a doctor?

Stop taking it and see a doctor the same day if you notice:

- Yellow skin or yellow whites of the eyes - Dark urine or pale stools - Pain under your right ribs that does not settle - Severe or sudden tiredness with loss of appetite - Nausea or vomiting that keeps going

Get emergency help for a swollen face or lips, a spreading rash, or trouble breathing.

If you have diabetes, check your blood sugar and seek advice for shakiness, sweating or confusion. These can be signs of low blood sugar.

Is Agaricus subrufescens legal where you live?

In the United States it is sold as a dietary supplement, not as an approved medicine. In the United Kingdom and the European Union it is sold as a food or food supplement, and health claims are restricted. Rules on sale differ by country, so check your local regulator.

Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.

The evidence behind this remedy, in one page

What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.

One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.